Commitments and Contingent Liabilities (Details Textual) |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
|
Dec. 31, 2015
USD ($)
shares
|
Dec. 31, 2015
ILS (₪)
₪ / shares
|
Dec. 31, 2015
EUR (€)
|
Dec. 31, 2014
USD ($)
|
Dec. 31, 2013
USD ($)
|
Dec. 31, 2011
USD ($)
|
Dec. 31, 2015
ILS (₪)
shares
|
|
| Commitments and Contingent Liabilities (Textual) | |||||||
| Rental expenses | $ 31,288 | $ 34,100 | $ 33,447 | ||||
| Operating lease, expiration date | Jul. 31, 2016 | Jul. 31, 2016 | Jul. 31, 2016 | ||||
| Research and development | $ 901,030 | 1,088,966 | 1,059,285 | ||||
| Warrants to purchase of ordinary shares | shares | 2,176,853 | 2,176,853 | |||||
| Annual license fee due during calendar year | $ 20,000 | ||||||
| Annual license fee due in second year | 20,000 | ||||||
| Annual license fee due in third year | 20,000 | ||||||
| Annual license fee due in fourth year | 50,000 | ||||||
| Annual license fee due in fivth year | 50,000 | ||||||
| Annual Llcense fee due in sixth year | 50,000 | ||||||
| Annual license fee due in seventh year | 75,000 | ||||||
| License fees | 20,000 | 20,000 | |||||
| Subsidiary received | 1,009,506 | ||||||
| Research and development agreement expense | 720,997 | 959,746 | 834,261 | ||||
| Aggregate consideration amounts | $ 1,400,000 | $ 60,000 | |||||
| Consolidation or merge description | The Company, upon the occurrence of certain Fundamental Transactions defined in the warrant agreement, mainly transactions involving a change in control of the Company, consolidation or merge with or into another entity; sale of all or substantially all of its assets, sale of 50% of its shares, etc. | The Company, upon the occurrence of certain Fundamental Transactions defined in the warrant agreement, mainly transactions involving a change in control of the Company, consolidation or merge with or into another entity; sale of all or substantially all of its assets, sale of 50% of its shares, etc. | The Company, upon the occurrence of certain Fundamental Transactions defined in the warrant agreement, mainly transactions involving a change in control of the Company, consolidation or merge with or into another entity; sale of all or substantially all of its assets, sale of 50% of its shares, etc. | ||||
| Royalty expenses | $ 2,177 | 5,184 | 0 | ||||
| Other commitments, description | Once the first ink (Silver Nano-Particle Ink) is certified by Xaar, the Company will be required to pay Xaar a fee for all certified inks sold for use with Xaar print heads as follows: 2% of the certified ink price until the cumulative value of the fees received by Xaar exceeds £50,000 ($74 thousands at December 31, 2015), and thereafter, 1% of the certified ink price. Once the cumulative value of the fees received by Xaar with respect to all products exceeds £1,000,000 ($1,482 thousands at December 31, 2015), the Company and Xaar have agreed to review the percentage payable in the light of the prevailing business conditions. | Once the first ink (Silver Nano-Particle Ink) is certified by Xaar, the Company will be required to pay Xaar a fee for all certified inks sold for use with Xaar print heads as follows: 2% of the certified ink price until the cumulative value of the fees received by Xaar exceeds £50,000 ($74 thousands at December 31, 2015), and thereafter, 1% of the certified ink price. Once the cumulative value of the fees received by Xaar with respect to all products exceeds £1,000,000 ($1,482 thousands at December 31, 2015), the Company and Xaar have agreed to review the percentage payable in the light of the prevailing business conditions. | Once the first ink (Silver Nano-Particle Ink) is certified by Xaar, the Company will be required to pay Xaar a fee for all certified inks sold for use with Xaar print heads as follows: 2% of the certified ink price until the cumulative value of the fees received by Xaar exceeds £50,000 ($74 thousands at December 31, 2015), and thereafter, 1% of the certified ink price. Once the cumulative value of the fees received by Xaar with respect to all products exceeds £1,000,000 ($1,482 thousands at December 31, 2015), the Company and Xaar have agreed to review the percentage payable in the light of the prevailing business conditions. | ||||
| License Agreement [Member] | |||||||
| Commitments and Contingent Liabilities (Textual) | |||||||
| License agreement aggregate amount | $ 376,000 | ₪ 1,467,683 | |||||
| Research and development | $ 276,000 | ₪ 1,077,000 | |||||
| Warrants to purchase of ordinary shares | shares | 117,209 | 117,209 | |||||
| Exercise price | ₪ / shares | ₪ 0.01 | ||||||
| Royalties description | Royalties of between 3.4% and 3.9% on all net sales of any product, component, device or material that is used in the preparation of coated substrates meeting certain specifications ("Licensed Film") and services resulting from the license; and royalties of between 2.4% and 3.0% on all net sales of Licensed Film products and services, and a sublicense fee at a rate of 25% of all sublicense fees the Company receives with respect to the intellectual property developed under such agreement. | Royalties of between 3.4% and 3.9% on all net sales of any product, component, device or material that is used in the preparation of coated substrates meeting certain specifications ("Licensed Film") and services resulting from the license; and royalties of between 2.4% and 3.0% on all net sales of Licensed Film products and services, and a sublicense fee at a rate of 25% of all sublicense fees the Company receives with respect to the intellectual property developed under such agreement. | Royalties of between 3.4% and 3.9% on all net sales of any product, component, device or material that is used in the preparation of coated substrates meeting certain specifications ("Licensed Film") and services resulting from the license; and royalties of between 2.4% and 3.0% on all net sales of Licensed Film products and services, and a sublicense fee at a rate of 25% of all sublicense fees the Company receives with respect to the intellectual property developed under such agreement. | ||||
| Company received amount | $ 0 | 16,330 | 140,765 | ||||
| Payments of royalties | 1,621 | 257 | |||||
| Total contingent liability | $ 1,352,819 | ||||||
| Research And Development Agreement [Member] | |||||||
| Commitments and Contingent Liabilities (Textual) | |||||||
| Royalties description | The Company's agreement to pay royalties of 5% of any revenues generated from the intellectual property generated under the program. The period of the program was 18 months starting January 1, 2012. | The Company's agreement to pay royalties of 5% of any revenues generated from the intellectual property generated under the program. The period of the program was 18 months starting January 1, 2012. | The Company's agreement to pay royalties of 5% of any revenues generated from the intellectual property generated under the program. The period of the program was 18 months starting January 1, 2012. | ||||
| Company received amount | $ 0 | 13,483 | $ 84,259 | ||||
| Payments of royalties | 1,147 | ||||||
| Total contingent liability | 178,559 | ||||||
| Research and development agreement expense | 160,000 | ₪ 625,000 | |||||
| Accrued royalties | $ 116 | 82 | |||||
| Convertible Bridge Financing Agreement [Member] | |||||||
| Commitments and Contingent Liabilities (Textual) | |||||||
| Royalties description | The Company committed to pay IEC royalties equal to 2% of the total net sales of the Company's products and service revenues from the product developed and manufactured through this agreement | The Company committed to pay IEC royalties equal to 2% of the total net sales of the Company's products and service revenues from the product developed and manufactured through this agreement | The Company committed to pay IEC royalties equal to 2% of the total net sales of the Company's products and service revenues from the product developed and manufactured through this agreement | ||||
| Accrued royalties | $ 4,336 | $ 3,799 | |||||
| Convertible bridge financing agreement amount | 2,050,000 | ₪ 8,000,000 | |||||
| Know How License Agreement [Member] | |||||||
| Commitments and Contingent Liabilities (Textual) | |||||||
| Payments of royalties | $ 27,000 | € 25 | |||||